Dalandang, Almaira .

HRN: 28-13-11  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2025
CEFUROXIME 750MG (VIAL)
11/20/2025
11/27/2025
IV
750mg
Q8
Anemia Sec To AUB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines